Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification

BACKGROUND: Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagen, Matthew W, Girdhar, Gaurav, Wainwright, John, Hinds, Monica T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629931/
https://www.ncbi.nlm.nih.gov/pubmed/27799376
http://dx.doi.org/10.1136/neurintsurg-2016-012612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629931/
https://www.ncbi.nlm.nih.gov/pubmed/27799376
http://dx.doi.org/10.1136/neurintsurg-2016-012612

Ejemplares similares